Georgetown University Medical Center and MedStar Georgetown University Hospital Collaborate on COVID-19 Antibody Study
May 7th, 2020
Georgetown University’s cancer-focused work takes place at Georgetown Lombardi Comprehensive Cancer Center, the only National Cancer Institute (NCI)-designated Comprehensive Cancer Center in the Washington area.
Georgetown Lombardi serves as the research engine for MedStar Health, its clinical partner.
Georgetown Lombardi is also an NCI recognized consortium with John Theurer Cancer Center/Hackensack Meridian Health in Bergen County, New Jersey. The consortium reflects an integrated cancer research enterprise with scientists and physician-researchers from both locations.
Georgetown Lombardi seeks to improve the diagnosis, treatment, and prevention of cancer through innovative basic, translational and clinical research, patient care, community education and outreach to service communities throughout the Washington region, while its consortium member John Theurer Cancer Center/Hackensack Meridian Health serves communities in northern New Jersey.
Georgetown Lombardi Launches COVID-19 Antibody Study in People with Cancer
April 29th, 2020
Adding Smoking Cessation to Lung Cancer Screening Can Reduce Mortality by 14%
March 9th, 2020
Georgetown Breast Cancer Researcher Inducted as AAAS Fellow
February 15th, 2020